Here are eight insights:
1. The company’s domestic revenue saw a 7 percent jump to $47.7 million, compared to the first quarter of 2016.
2. International revenue increased to $21.8 million in the first quarter of 2017, a 5 percent jump from the same period the year prior.
3. Exactech’s earnings per share was $0.32 in the first quarter of 2017 based on net income of $4.6 million.
4. The company’s extremity revenues experienced a 21 percent boost from the first quarter of 2016, up to $24.8 million in the first quarter of 2017.
5. Knee revenue increased to $20 million in the first quarter of 2017, up 1 percent from the same period the year prior.
6. Hip revenue jumped 6 percent to $12.1 million in the first quarter of 2017, up from the first quarter of 2016.
7. Other revenues, including an aggregation of the former biologics and spine segment, saw a 20 percent dip to $7.3 million in the first quarter of 2017.
8. Exactech updated its 2017 revenue guidance to between $266 and $272 million and increased its diluted EPS target to between $1.24 and $1.30.
More articles on devices:
Dr. David Ruch performs 1st surgery using OsteoMATE arthrodesis implant — 4 key notes
Nexxt Spine releases INERTIA CORTI-FIXX pedicle screw system — 4 details
Inspired Spine publishes ebook on OLIF & OLLIF procedures: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
